Physician profile
Jeffrey M Jacobs
NPI 1972582708
$1,100.89
in general payments reported to CMS, 2019-2025
21 companies · $19.62 in 2025
The $19.62 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $207 · 2021: $106 · 2022: $36.94 · 2023: $140 · 2024: $188 · 2025: $19.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $249.47 | 2019-2023 | Grafix, Grafix Pl |
| Kerecis Limited | $129.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Medtronic Vascular, INC. | $117.82 | 2019 | |
| Novo Nordisk INC | $96.31 | 2019-2020 | |
| Amarin Pharma, INC. | $71.45 | 2020-2021 | |
| Organogenesis INC. | $67.13 | 2022-2024 | Puraply |
| Integra Lifesciences Corporation | $65.64 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $58.35 | 2019-2021 | |
| Reapplix INC. | $49.38 | 2024-2025 | 3c Patch Kit - Box |
| Medtronic, INC. | $28.63 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.00 | 2020 | |
| Stryker Corporation | $17.55 | 2023 | Fuseforce |
| Viiv Healthcare Company | $15.25 | 2020 | |
| Medtronic Minimed, INC. | $15.00 | 2019 | |
| Next Science LLC | $14.59 | 2023 | Xperience, Surgx, Blastx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.23 | 2020 | |
| Ibsa Pharma INC. | $13.39 | 2023 | Tirosint, Licart |
| Lilly USA, LLC | $12.85 | 2019 | |
| Treace Medical Concepts, INC. | $12.50 | 2022 | |
| Glaxosmithkline, LLC. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.